// App-Quantinova.ai

: Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase

Researchers

Presenter

  • Mark Gurnell

Principal Investigators

  • Liam G. Heaney

  • Andrew Menzies-Gow

  • Jonathan Corren

  • Elisabeth H. Bel

  • Jorge Maspero

  • Timothy Harrison

  • David J. Jackson

  • David Price

  • Njira Lugogo

  • Annie Burden

  • Alex De Giorgio-Miller

  • Kelly Padilla

  • Ubaldo J. Martin

  • Esther Garcia Gil

  • James Kreindler

Medical Centers

  • Wellcome-MRC Institute of Metabolic Science, University of Cambridge & NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, United Kingdom

  • Fundacion GADOR, Buenos Aires, Argentina

  • Nottingham Respiratory Research Unit, University of Nottingham, Nottingham, Notts, United Kingdom

  • AstraZeneca, Barcelona, Spain.

  • Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

  • Astra Zeneca, Cambridge, United Kingdom

  • Guy's Severe Asthma Center, Guy’s & St. Thomas’ NHS Trust & Asthma UK Centre, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom

  • Observational and Pragmatic Research Institute, Singapore, Singapore,

  • David Geffen School of Medicine at UCLA and Allergy Medical Clinic Inc., Los Angeles, United States of America

  • University of Michigan School of Medicine, Ann Arbor, United States of America

  • AstraZeneca Gaithersburg, Gaithersburg, United States of America

  • Centre for Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom

  • Royal Brompton & Harefield Trust, London, United Kingdom

  • AstraZeneca, Royston, United Kingdom

Locations

  • United States

  • United Kingdom

  • Argentina

  • Singapore

  • Netherlands

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Benralizumab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A